H.J. Res. 76 is a joint resolution using the Congressional Review Act (chapter 8 of title 5) to disapprove the Environmental Protection Agency’s rule titled “Updates to New Chemicals Regulations Under the Toxic Substances Control Act (TSCA)” (89 Fed.
Reg. 102773; Dec. 18, 2024). The text is short: it names the rule by citation and declares that the rule “shall have no force or effect.”
The resolution matters because nullifying an EPA TSCA rule would erase a recent federal regulatory change that affects how new chemicals are reviewed and cleared for market. If enacted, the resolution would not rewrite TSCA itself; instead it would remove the specific EPA regulatory update and trigger statutory consequences under the CRA that constrain how the agency can try to address the same subject again.
At a Glance
What It Does
The resolution disapproves and nullifies the EPA’s December 18, 2024 rule updating new-chemical regulations under TSCA, by name and Federal Register citation. It invokes chapter 8 of title 5 (the Congressional Review Act) as the vehicle for disapproval.
Who It Affects
EPA and regulated parties subject to TSCA new-chemical review — including chemical manufacturers, importers, and downstream processors — would see the December 2024 regulatory changes removed. States and NGOs that relied on the updated standards would also be affected by the rollback.
Why It Matters
A successful CRA disapproval both strips a recent administrative change and limits the agency’s ability to reissue a substantially similar rule, creating a durable regulatory barrier without altering the underlying statute. That creates immediate compliance changes and longer-term strategic consequences for regulators and industry.
More articles like this one.
A weekly email with all the latest developments on this topic.
What This Bill Actually Does
H.J. Res. 76 is narrowly drafted: it identifies the EPA rule by title and Federal Register citation and states that Congress disapproves it, so the rule “shall have no force or effect.” The resolution uses the Congressional Review Act (CRA) mechanism, which is designed for Congress to overturn recently finalized federal rules by passing a joint resolution of disapproval.
If enacted, the resolution would nullify the December 18, 2024 amendments to EPA’s new-chemicals regulations under TSCA. Nullification under the CRA means the specific regulatory text in that rule would be treated as if it were never in force; regulated entities would revert to the prior regulatory framework that applied before that Federal Register notice took effect.Beyond immediate nullification, the CRA creates a follow-on constraint: the agency may not reissue a rule that is “substantially the same” as the disapproved rule unless Congress subsequently authorizes it.
That limit can force EPA to pursue materially different regulatory approaches, rely on informal guidance, or seek legislative changes to accomplish goals that the disapproved rule attempted to achieve.The resolution does not attempt to amend TSCA, set alternative technical standards, or prescribe specific regulatory language. It operates purely as a disapproval instrument: remove the agency action, and leave the statutory baseline—TSCA itself—unchanged.
The practical effect for regulated companies and EPA will therefore be operational (which procedures and requirements apply) and strategic (how to pursue chemical-review policy going forward).
The Five Things You Need to Know
The resolution targets EPA’s rule “Updates to New Chemicals Regulations Under the Toxic Substances Control Act (TSCA),” published at 89 Fed. Reg. 102773 on December 18, 2024.
It invokes chapter 8 of title 5, United States Code — the Congressional Review Act — as the statutory vehicle for disapproval.
The single operative sentence declares that Congress disapproves the rule and that the rule “shall have no force or effect.”, Under the CRA, enactment would bar EPA from reissuing a rule that is “substantially the same” as the disapproved rule unless Congress authorizes it.
The resolution does not amend TSCA or replace the rule with alternative regulatory requirements; it simply removes the December 2024 regulatory text and leaves the prior regulatory baseline in place.
Section-by-Section Breakdown
Every bill we cover gets an analysis of its key sections.
Short title and identification of rule
This introductory portion names the joint resolution and identifies the agency rule by its official title and Federal Register citation. That precise identification is how the CRA procedure pins the disapproval to a single, discrete agency action rather than to a broader programmatic change.
Disapproval language
This is the operative text: a succinct declaration that Congress disapproves the specified EPA rule and that the rule shall have no force or effect. There is no carve-out, phase-out, or transitional mechanism; the language is categorical, which means the rule is nullified outright if the resolution becomes law.
CRA consequences for agency action
By invoking chapter 8 of title 5, the resolution triggers the Congressional Review Act’s legal consequences. Practically, nullification will restore the preexisting regulatory status quo and simultaneously impose the CRA’s bar on reissuing a substantially similar rule without congressional authorization. That consequence shapes EPA’s options for addressing the same policy objectives in the future.
No statutory change to TSCA or EPA’s authority
The text does not amend the Toxic Substances Control Act or change EPA’s statutory authority. The resolution acts only on the specific regulatory text published in the Federal Register; any longer-term changes to chemical-approval processes would still require separate rulemaking or statutory amendment.
This bill is one of many.
Codify tracks hundreds of bills on Environment across all five countries.
Explore Environment in Codify Search →Who Benefits and Who Bears the Cost
Every bill creates winners and losers. Here's who stands to gain and who bears the cost.
Who Benefits
- Chemical manufacturers and importers — Removing the December 2024 rule preserves the prior regulatory baseline they were already complying with and avoids any new compliance obligations or testing requirements the updated rule may have introduced.
- Downstream users and processors that depend on predictable chemical-entry timelines — Nullification can maintain existing approval timelines and reduce the near-term need to adapt supply-chain approvals to new procedural steps.
- Companies that challenged or opposed the rule — Those who viewed the rule as more burdensome avoid near-term costs and retain established business practices while regulators and lawmakers revisit the issue.
Who Bears the Cost
- EPA — Nullifying a finalized rule erases a regulatory tool the agency adopted to change how new chemicals are assessed, and the CRA bar limits EPA’s ability to pursue the same approach promptly.
- Public health and environmental advocacy groups — These stakeholders lose the protections or procedural steps the December 2024 rule may have added for assessing risks of new chemicals.
- State regulators seeking a stronger federal floor — States that anticipated relying on the updated federal standard may face gaps or inconsistent approaches if the federal rule is removed.
- Compliance officers and legal teams — Even beneficiaries incur costs: businesses and agencies must reassess regulatory strategy, potentially unwind implementation plans, and plan for uncertain future regulatory pathways.
Key Issues
The Core Tension
The central dilemma is between congressional oversight that nullifies perceived agency overreach and the need for agencies to develop and update technically detailed, science-based regulatory systems: using the CRA to strike a rule resolves one set of concerns quickly but also removes a regulatory tool designed to address public-health risks, potentially locking both regulators and stakeholders into an older, less-updated regime.
The resolution’s blunt instrumentality is the root of several practical risks. Nullifying a rule wholesale removes administrative detail without substituting a policy alternative; that creates a regulatory gap that courts, regulated entities, and states must navigate.
The CRA’s ban on reissuing a “substantially the same” rule is powerful but imprecise: agencies must decide how different a new rule must be to escape the bar, which invites legal challenges and uncertainty about permissible regulatory design choices.
Implementation questions remain unresolved by the resolution itself. Because the text does not modify TSCA, EPA still possesses statutory duties under that statute, but its pathway to meet those duties is constrained.
EPA could pursue materially different regulatory language, rely more heavily on guidance or informal actions, or seek legislative fixes — each path has trade-offs in speed, durability, and defensibility in court. For regulated firms the immediate effect may be simpler compliance, but the medium-term picture is increased policy uncertainty: industry cannot reliably predict whether EPA will return with a retooled rule, pursue enforcement differently, or leave gaps that state regulators will attempt to fill.
Try it yourself.
Ask a question in plain English, or pick a topic below. Results in seconds.